2016
DOI: 10.1021/acs.jmedchem.6b00770
|View full text |Cite
|
Sign up to set email alerts
|

Functional Characterization of Cholera Toxin Inhibitors Using Human Intestinal Organoids

Abstract: Preclinical drug testing in primary human cell models that recapitulate disease can significantly reduce animal experimentation and time-to-the-clinic. We used intestinal organoids to quantitatively study the potency of multivalent cholera toxin inhibitors. The method enabled the determination of IC50 values over a wide range of potencies (15 pM to 9 mM). The results indicate for the first time that an organoid-based swelling assay is a useful preclinical method to evaluate inhibitor potencies of drugs that ta… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

3
51
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 45 publications
(54 citation statements)
references
References 26 publications
3
51
0
Order By: Relevance
“…This way, a K d value of 600 ± 20 nM was obtained for carbohydrate 1 and a K d value of 90 ± 50 nM for carbohydrate 2. While we cannot directly compare K d values with IC 50 values of competition experiments or swelling inhibition, the differences between the two compounds of close to an order of magnitude are in reasonable agreement with those of our previously described IC 50 values using the common ELISA assay and the newly developed assay based on organoid swelling inhibition [10]. As such the method is capable of differentiating compounds of relatively similar binding or inhibitory potency, even though the assay was run at pH 4 rather than the usual neutral condition in, for example, the ELISA assay.…”
supporting
confidence: 80%
See 1 more Smart Citation
“…This way, a K d value of 600 ± 20 nM was obtained for carbohydrate 1 and a K d value of 90 ± 50 nM for carbohydrate 2. While we cannot directly compare K d values with IC 50 values of competition experiments or swelling inhibition, the differences between the two compounds of close to an order of magnitude are in reasonable agreement with those of our previously described IC 50 values using the common ELISA assay and the newly developed assay based on organoid swelling inhibition [10]. As such the method is capable of differentiating compounds of relatively similar binding or inhibitory potency, even though the assay was run at pH 4 rather than the usual neutral condition in, for example, the ELISA assay.…”
supporting
confidence: 80%
“…Of these, multivalent inhibitors based on the ganglioside GM1- Abbreviations: eff , electrophoretic mobility; CTB, cholera toxin B-subunit; GM1os, ganglioside GM1-oligosaccharide; H5, influenza hemagglutinin; K d , dissociation constant oligosaccharide (GM1os) have shown the highest inhibitory potency [8,9], however more development of cheaper and still effective compounds is expected, for which new assay methods are required. Recently we demonstrated that an assay based on the swelling of intestinal organoids provides a biorelevant alternative to the in vivo rabbit ileal loop assay [10], which is notoriously time-consuming, difficult, and stressful for the animals [11]. A drawback is the limited availability of the organoids.…”
mentioning
confidence: 99%
“…The combination of simple inhibitors into multivalent constructs has been proposed before as effective antagonists of CT action in Vibrio cholerae infections 42, 49 . One of the inhibitors shows the surprising capability to facilitate bridging to nearby toxins.…”
Section: Discussionmentioning
confidence: 99%
“…While enteroids are biologically relevant models for infectious diarrheal diseases (16,17,22,23), their suitability as a platform to study ST-induced intestinal secretion remains unknown (17). Since previous studies demonstrated that pharmacological agents, including complex multimeric proteins like cholera toxin, readily access the lumen of enteroids (25,26), we predicted that these organoids should respond to GUCY2C ligands. Here, we reveal the ability of mouse and human enteroids to respond to ST and its homologs in a GUCY2C-dependent fashion, providing a high-throughput biologically relevant model to explore the pathophysiology of ST and screen antisecretory agents to treat and prevent diarrheal disease.…”
mentioning
confidence: 99%